Currently browsing

Andrea Cassells

Do pharmaceutical marketing and pricing practices reduce compliance with cardiovascular medications?

April 1, 2008 | By , ,

Cardiovascular disease (CVD) is the most prevalent condition treated in primary care practice and contributes to the socioeconomic and racial/ethnic inequities in health that characterize the U.S. Treating hypertension and hyperlipidemia, CVD’s major risk factors, can significantly reduce the risk of severe cardiovascular outcomes. Although safe and effective medications are …

Read more >